Teladoc Health jumps after third-quarter revenue beats estimates
TDOC•Teladoc Health reported third-quarter revenue of $605.10 million, above analysts’ estimate of $588.5 million, and its shares rose 9.4% in extended trading. The company expects 2026 revenue of $2.40 billion to $2.44 billion and fourth-quarter revenue of $569 million to $615 million.
1. Revenue and outlook
Teladoc Health reported third-quarter revenue of $605.10 million, exceeding analysts’ estimate of $588.5 million. It expects 2026 revenue of $2.40 billion to $2.44 billion, compared with analysts’ estimate of $2.41 billion, and fourth-quarter revenue of $569 million to $615 million, versus estimates of $597.39 million. Shares rose 9.4% to $7.53 in extended trading; the stock was down 1.7% year to date as of the last close.
